TargetVasopressin V2 receptor(Homo sapiens (Human))
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataKi: 1.90nMAssay Description:Inhibition of [3H]AVP binding to recombinant human vasopressin V2 receptorMore data for this Ligand-Target Pair
TargetVasopressin V2 receptor(Homo sapiens (Human))
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataKi: 2nMAssay Description:Inhibition of 1 nM AVP-induced cAMP accumulation in cells expressing human vasopressin V2 receptorMore data for this Ligand-Target Pair